# A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

> **NCT07206810** · — · COMPLETED · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 419 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** Bortezomib, Lenalidomide, and Dexamethasone

## Key facts

- **NCT ID:** NCT07206810
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07206810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07206810, "A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07206810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*